News

Article

Psychedelics Beyond Clinical Settings Poll

Author(s):

Psychiatric Times Editors

Answer a quick question on psychedelics!

Have your patients shared or expressed interest in psychedelics for therapeutic purposes outside of clinical settings?

Yes, patient(s) have shared their interest
No, patient(s) have not talked about it
Related Videos
Related Content
ketamine
October 30th 2024

Psychiatrists Utilizing Ketamine-Assisted Psychotherapy

Miriam Schultz, MD
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
John Krystal, MD: Exploring the Future of Ketamine and Psychedelic Treatment
September 20th 2024

John Krystal, MD: Exploring the Future of Ketamine and Psychedelic Treatment

Heidi Anne Duerr, MPH John H. Krystal, MD
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
cannabis
September 12th 2024

Psychiatry’s Risky Gamble on Recreational Drugs: The Royal Road to the Unconscious or Down a Pharmacologic Garden Path

Jeffrey A. Lieberman, MD Nico Warren
psychedelics
September 11th 2024

With MDMA on Hold, What’s Next for Psychedelics?

Heidi Anne Duerr, MPH
© 2024 MJH Life Sciences

All rights reserved.